| 18q LOH status | Total N | CIMP-0 (0/8)a | CIMP-low/high (1/8 – 8/8)a | P value | CIMP-low (1/8 – 5/8) | CIMP-high (6/8 – 8/8) |
---|---|---|---|---|---|---|---|
Men | (+) | 104 | 59 (57%) | 45 (43%) | 0.02 | 41 (39%) | 4 (3.8%) |
 | (-) | 70 | 28 (40%) | 42 (60%) |  | 39 (56%) | 3 (4.3%) |
Women | (+) | 132 | 80 (61%) | 52 (39%) | Â | 47 (36%) | 5 (3.8%) |
 | (-) | 68 | 33 (49%) | 35 (51%) |  | 30 (44%) | 5 (7.4%) |
Right colon | (+) | 45 | 19 (42%) | 26 (58%) | Â | 23 (51%) | 3 (6.7%) |
 | (-) | 37 | 12 (32%) | 25 (68%) |  | 21 (57%) | 4 (11%) |
Left colon | (+) | 87 | 54 (62%) | 33 (38%) | Â | 32 (36%) | 1 (1.9%) |
 | (-) | 34 | 16 (47%) | 18 (53%) |  | 18 (53%) | 0 |
p53(+)^ | (+) | 122 | 73 (60%) | 49 (40%) | Â | 48 (39%) | 1 (0.8%) |
 | (-) | 43 | 19 (44%) | 24 (56%) |  | 22 (51%) | 2 (4.7%) |
p53(-)^ | (+) | 113 | 66 (58%) | 47 (42%) | 0.03 | 39 (35%) | 8 (7.1%) |
 | (-) | 90 | 39 (43%) | 51 (57%) |  | 45 (50%) | 6 (6.7%) |
KRAS(-) BRAF(-) | (+) | 142 | 93 (65%) | 49 (35%) | Â | 47 (33%) | 2 (1.4%) |
 | (-) | 51 | 30 (59%) | 21 (41%) |  | 21 (41%) | 0 |
KRAS(+) BRAF(-) | (+) | 71 | 39 (55%) | 32 (45%) | Â | 31 (44%) | 1 (1.4%) |
 | (-) | 72 | 30 (42%) | 42 (58%) |  | 39 (54%) | 3 (4.2%) |
KRAS(-) BRAF(+) | (+) | 17 | 3 (18%) | 14 (82%) | Â | 8 (47%) | 6 (35%) |
 | (-) | 12 | 0 | 12 (100%) |  | 7 (58%) | 5 (42%) |